Dr. Jan Deprest is a leading international fetal surgeon who works two days
a week at UCLH as a consultant and at UCL as a professor of obstetrics and gynaecology.
At UCL, he works in the Institute for Women’s Health and the Translational
Imaging Group. His home institution is at the Katholieke Universiteit Leuven
and its University Hospitals Leuven (Belgium). Dr. Deprest is currently Academic Chair of the Department of Development and Regeneration and Director
of the Centre for Surgical Technologies. Clinically, he is the director of the
fetal surgery programme in Leuven. He trained in fetal medicine in Leuven
(Belgium), St George’s Hospital London (UK), Leiden (Holland) and attended the
programme at Children’s Hospital Philadelphia (PA, USA). He established the
Eurofoetus consortium, which is dedicated to the development of instruments and
techniques for minimally invasive fetal and placental surgery. He has headed
several clinical studies dedicated to the prenatal prediction of survival of
fetuses with isolated CDH using genetic testing, ultrasound, and fetal MRI
imaging. He developed a percutaneous method for fetoscopic placement of a
balloon into the fetal trachea (FETO). In a European task force together with
the University of Barcelona (Hospital Clinic) and London (King’s College
Hospital) the team performed over 200 such procedures by 2009.
Dr. Jan Deprest is a leading international fetal surgeon who works two days
a week at UCLH as a consultant and at UCL as a professor of obstetrics and gynaecology.
At UCL, he works in the Institute for Women’s Health and the Translational
Imaging Group. His home institution is at the Katholieke Universiteit Leuven
and its University Hospitals Leuven (Belgium). Dr. Deprest is currently Academic Chair of the Department of Development and Regeneration and Director
of the Centre for Surgical Technologies. Clinically, he is the director of the
fetal surgery programme in Leuven. He trained in fetal medicine in Leuven
(Belgium), St George’s Hospital London (UK), Leiden (Holland) and attended the
programme at Children’s Hospital Philadelphia (PA, USA). He established the
Eurofoetus consortium, which is dedicated to the development of instruments and
techniques for minimally invasive fetal and placental surgery. He has headed
several clinical studies dedicated to the prenatal prediction of survival of
fetuses with isolated CDH using genetic testing, ultrasound, and fetal MRI
imaging. He developed a percutaneous method for fetoscopic placement of a
balloon into the fetal trachea (FETO). In a European task force together with
the University of Barcelona (Hospital Clinic) and London (King’s College
Hospital) the team performed over 200 such procedures by 2009.